Randomized Clinical Trial
Copyright ©The Author(s) 2022.
World J Cardiol. Dec 26, 2022; 14(12): 626-639
Published online Dec 26, 2022. doi: 10.4330/wjc.v14.i12.626
Table 2 Distribution of characteristics in hypertensive subjects following a virtual anti-hypertensive educational campaign
Characteristics
Intervention, n = 55
Control, n = 55
P value
Sex
Male22 (40.0)19 (34.5)0.23
Female33 (60.0)36 (65.5)
Age group, yr
< 2001 (1.8)0.33
20-293 (5.4)4 (7.2)
30-3912 (21.8)10 (18.2)
40-4919 (34.5)20 (36.4)
50-5916 (29.1)16 (29.1)
60-694 (7.2)2 (3.6)
> 701 (1.8)2 (3.6)
Marital status
Single2 (3.6)1 (1.8)0.35
Married30 (54.5)29 (52.7)
Widowed23 (41.8)25 (45.4)
Religion
Muslim42 (76.4)47 (85.5)0.28
Christianity9 (16.4)5 (9.1)
Others4 (7.2)3 (5.4)
Educational degree
Not attending4 (7.2)4 (7.2)0.41
Elementary school16 (29.1)18 (32.7)
Junior high school8 (14.5)5 (9.1)
Senior high school20 (36.4)19 (34.5)
Diploma5 (9.1)4 (7.2)
Undergraduate2 (3.6)4 (7.2)
Graduate (magister)01 (1.8)
Occupation
Civil servants2 (3.6)3 (5.4)0.38
Police1 (1.8)0
Laborers7 (12.7)4 (7.2)
Entrepreneurs5 (9.1)7 (12.7)
Private workers5 (9.1)4 (7.2)
Housewives25 (45.5)29 (52.7)
Retired10 (18.2)8 (14.5)
Antihypertensive drugs
ACE-inhibitor17 (30.9)15 (27.3)0.27
ARBs2 (3.6)1 (1.8)
Beta blocker3 (5.4)2 (3.6)
CCBs31 (56.4)29 (52.7)
Diuretics2 (3.6)8 (14.5)
Baseline systolic BP153 ± 15 mmHg151 ± 15 mmHg0.49
Baseline diastolic BP96 ± 13 mm Hg91 ± 13 mm Hg0.42